Tag Archives: Treatments

Cancer: Breakthrough treatments to target drug resistance

The world’s first drugs designed to stop cancer cells becoming resistant to treatment could be available within the next decade, scientists have said. A £75m investment to develop the drugs has been announced by the Institute of Cancer Research (ICR). Chief executive Prof Paul Workman said cancer’s ability to adapt to drugs is the biggest… Read More »

FDA Approves New Treatments Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) for Heart Disease Caused by Transthyretin Mediated Amyloidosis

Print this page May 06, 2019 — On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. Vyndaqel and Vyndamax have the same active… Read More »